TheraRadar
Data updated: May 26, 2026

JAIMIESS (ethinyl estradiol)

Women's Health Approved 2017-12-27

Jaimiess is a combination medication used by females of reproductive potential to prevent pregnancy. It combines two different hormones, levonorgestrel and ethinyl estradiol, to provide contraceptive protection. This medication is prescribed for individuals who wish to avoid conception through a hormonal approach.

Source: FDA Label • XIROMED

How JAIMIESS Works

This medication works by suppressing ovulation, which is the primary way it prevents pregnancy. By combining a progestin and an estrogen, it interferes with the normal reproductive cycle to ensure that an egg is not released.

Source: FDA Label
1
Indication
--
Phase 3 Trials
8
Years on Market

Details

Status
Prescription
First Approved
2017-12-27
Routes
ORAL
Dosage Forms
TABLET

Companies

Active Ingredient: ETHINYL ESTRADIOL , LEVONORGESTREL

JAIMIESS Approval History

2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2017 to 2023
Nov 2023 SUPPL
Label · Labeling
Dec 2017 ORIGINAL
Update

What JAIMIESS Treats

1 indications

JAIMIESS is approved for 1 conditions since its original approval in 2017. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Pregnancy prevention
Source: FDA Label

JAIMIESS Boxed Warning

CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including Jaimiess, are contraindicated in women who are over 35 years of age and smoke. [See Contraindications ( 4 ) and Warnings and Precautions ( 5.1 )]. WARNING: CIGARETTE SMOKING AND SER...

JAIMIESS Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to JAIMIESS

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMABELZ
ESTRADIOL
1 shared
Lupin
Shared indications:
Pregnancy prevention
ANNOVERA
ETHINYL ESTRADIOL
1 shared
MAYNE PHARMA
Shared indications:
Pregnancy prevention
ASHLYNA
ETHINYL ESTRADIOL
1 shared
GLENMARK PHARMS LTD
Shared indications:
Pregnancy prevention
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT07340190 CDAK539A12102 2025-521000-22-00 Ph 1 not yet recruiting A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
NCT06039826 18533 J1I-MC-GZBV Ph 1 completed A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

JAIMIESS FDA Label Details

Indications & Usage

JAIMIESS is indicated for the treatment of Pregnancy prevention.

⚠️ BOXED WARNING

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For t...

Track JAIMIESS with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.